Telix Joins Thera4Care with TLX400-Tx to Accelerate Translation of Next Generation FAP

·5h ago
Share:PostShare

Thera4Care is an initiative aimed at establishing an integrated theranostics ecosystem to broaden patient access in Europe Telix's fibroblast activation protein (FAP) targeting therapy candidate (TLX400-Tx) has been selected for evaluation with terbium-161 based on clinical potential and...

P

Pr Newswire Apac

Original source

Read full story

Related Stories

Health11h ago

EU cancer groups fear funding squeeze under next long

As European Union countries negotiate funding allocations for the bloc’s next long-term budget, cancer organisations fear that projects spanning from research to personalised care and patient support could be discontinued, weakening cancer care across Europe.

EEuronews

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer